and they've her some professor of pathology university of edinburgh and director of the breakthrough
breast cancer research unit
so the unit here's come together to apply a lot of different scales all to
study breast cancer and particularly asian to breast cancer getting sheet with and unfair i
and patients who will ultimately fail to respond factory and so what we're focused on
here is trying to understand real human breast cancer in real patients and to understand
why treatment sometimes work and then stop working
recent data that we've published is built on some early success in the unit which
is to identify subpopulations of cancer patients will likely to benefit from a particular type
of therapy
and in this particular study we make some translation of our findings within the look
more tree
and identified that this potentially a population of breast cancer patients you might benefit from
a new type of therapy but these are really findings but hopefully this opportunity to
test this in logic clinical trials
the breakthrough bob is great because we are located directly above the breast contact and
so we see patients coming and the on a daily basis and it helps to
provide the motivation for us to continue to were card and as well we occasionally
can get time to more samples from and
the unit downstairs in can study those in detail
we made a lot of progress breast cancer over the last ten twenty year survival
is much better than a lot of drugs are very effective what we're not very
good not yet is giving the right person precisely the right treatment for them
so we tend to be patients in groups so what we are seeking to do
with a whole host of different scales and project is you to trying to figure
out how can we personalise somebody's anti cancer treatment so it is the very best
chance for them as an individual